In the BioHarmony Drug Report Database
Mercaptamine
Cystagon, Procysbi (cysteamine) is a small molecule pharmaceutical. Cysteamine was first approved as Cystagon on 1994-08-15. It is used to treat cystinosis in the USA. Cystagon’s patents are valid until 2036-08-16 (FDA).
Trade Name
|
Cystagon, Procysbi |
|---|---|
Common Name
|
cysteamine |
ChEMBL ID
|
CHEMBL602 |
Indication
|
cystinosis |
Drug Class
|
Image (chem structure or protein)